肌萎缩侧索硬化症患者中神经退行性疾病相关基因变异与表型异质性
一项病例对照研究纳入791例ALS患者和747名匹配对照,通过全基因组测序发现16.1%的ALS患者携带至少一个神经退行性疾病相关基因的罕见高影响变异,显著高于对照的12.2%(OR 1.37;95%CI 1.04-1.80;p=0.027)。这些变异增加ALS风险,并与连枷臂表型、额颞叶痴呆风险增加及生存期缩短相关,并在Project MinE数据集中得到独立验证。
要点
- ALS患者中神经退行性疾病相关基因罕见变异富集,增加ALS风险(OR 1.37;95%CI 1.04-1.80;p=0.027)。
- 帕金森病相关基因新发变异和遗传性神经病基因变异分别 confer 约3倍风险增加。
- 变异携带者更易出现连枷臂表型、额颞叶痴呆风险增加及生存期缩短。
核心结论
- 神经退行性疾病相关基因的罕见变异影响ALS易感性和临床特征,提示跨疾病遗传多效性。
研究设计与样本
- 基于人群的病例对照研究,纳入791例无主要ALS基因致病变异的ALS患者和747名匹配对照,进行全基因组测序。
- 在Project MinE数据集(6,596例ALS患者,2,454名对照)中进行重复验证。
主要发现
- 帕金森病相关基因新发变异(OR 3.62;95%CI 1.33-9.80;p=0.01)和遗传性神经病基因变异(OR 3.30;95%CI 1.55-7.03;p=0.002)与约3倍风险增加相关。
- 在Project MinE数据集中独立重复验证(OR 1.43;95%CI 1.30-1.57;p<0.001)。
- 变异携带者更易表现为连枷臂表型(OR 2.05;95%CI 1.05-3.98;p=0.03),额颞叶痴呆风险增加(OR 1.85;95%CI 1.04-3.21;p=0.03),生存期缩短(HR 1.99;95%CI 1.26-3.14;p=0.003)。
临床怎么用
- 临床可考虑对ALS患者扩展遗传筛查至其他神经退行性疾病相关基因,但需谨慎解读。
- 识别这些变异有助于预测表型变异和预后,但需进一步功能验证。
局限性
- 这些变异在临床实践中的解读应谨慎,需等待进一步功能验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The genetic contribution to clinical heterogeneity in amyotrophic lateral sclerosis (ALS) remains poorly understood, particularly regarding the role of genes associated with other neurodegenerative disorders. This study aimed to determine whether rare variants in neurodegeneration-associated genes influence ALS risk and clinical phenotype. METHODS: This case-control study included patients with ALS without pathogenic variants in major ALS genes from the population-based Piemonte and Valle d'Aosta Register for ALS and matched controls. High-impact rare variants (minor allele frequency <0.01% or novel) in 151 genes associated with neurodegenerative disorders were identified through whole-genome sequencing. Main outcomes included ALS risk, motor phenotype, cognitive status, and survival. Findings were replicated in the Project MinE dataset (6,596 ALS cases, 2,454 controls). RESULTS: The study population consisted of 791 ALS patients (median age 67.9 years; 46.3% women) and 747 matched controls. One hundred twenty-seven ALS cases (16.1%) carried at least one rare variant in neurodegeneration-associated genes compared with 91 (12.2%) controls (odds ratio [OR] 1.37; 95% CI 1.04-1.80; p = 0.027). In particular, novel variants in Parkinson disease-associated genes (OR 3.62; 95% CI 1.33-9.80; p = 0.01) and hereditary neuropathy genes (OR 3.30; 95% CI 1.55-7.03; p = 0.002) conferred a 3-fold increased risk. These findings were independently replicated in the Project MinE dataset (OR 1.43; 95% CI 1.30-1.57; p < 0.001). Stratified analysis also confirmed the enrichment of rare variants in Parkinson disease and hereditary neuropathy-associated genes. Variant carriers were more likely to present with the flail arm phenotype (OR 2.05; 95% CI 1.05-3.98; p = 0.03) and showed increased risk of frontotemporal dementia (OR 1.85; 95% CI 1.04-3.21; p = 0.03) and shorter survival (hazard ratio 1.99; 95% CI 1.26-3.14; p = 0.003). DISCUSSION: Rare variants in genes associated with other neurodegenerative disorders influence both ALS susceptibility and clinical features, highlighting genetic pleiotropy across neurodegenerative diseases. Our findings support a model in which ALS arises from a complex and heterogeneous genetic landscape involving multiple variants, often shared with other neurodegenerative conditions, that shape disease expression. Although these findings suggest potential future expansion of genetic screening beyond classical ALS genes, such variants should be interpreted cautiously in clinical practice pending further functional validation.
引用
- Grassano M, Koumantakis E, Palumbo FF, et al. Genetic Variants Associated With Neurodegenerative Disorders in Patients With Amyotrophic Lateral Sclerosis and Phenotypic Variability. Neurology. 2025. PMID: 40997283. doi:10.1212/WNL.0000000000214180
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。